Switch View
© BusinessWire
30.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants
News Preview
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten public offering of 23,809,524 shares of its common stock at a price of $4.20 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 7,142,85...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Reports Third Quarter 2025 Results
News Preview
BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025.
This was...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek appointment as lead plaintif...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
30.10.2025
ISIN: KYG0519B1023
Ascentage Pharma Group International
6855
LISTED
HKSE
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
News Preview
ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
29.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
News Preview
PHILADELPHIA, Oct. 29, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Therapeutics, Inc. ("Akero" or the "Company") about an investigation into the Company and members of its Board of Directors for potential breaches of fiduciary duties and violations of the federal securities laws....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
News Preview
Châtillon, France, October 29, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: DE0005550602
Draegerwerk AG & Co KGaA
DRW8
LISTED
XETR
Dräger achieves perfect-score CMMC Level 2 Certification reinforcing cybersecurity leadership in Defense and Government healthcare and safety technology
News Preview
Certification ensures the highest level of data security for mission-critical medical and safety technology
TELFORD, Pa., Oct. 29, 2025 /PRNewswire/ -- Draeger, Inc., part of the Dräger group of corporations ('Dräger') and a leading provider of medical and safety technology, has achieved Cybersecu...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries
News Preview
ROCKVILLE, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced that its subsidiary Visara, Inc. (Visara) has assigned it exclusive license agreement to Everest Medicines (HKEX: 1952...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
News Preview
Allergan Aesthetics gives patients exciting BOTOX® Cosmetic offers only in the Allē app
Buy one $50 gift card, get one free, plus, register, book a consultation, and get treated for a chance to win $25,000*†
IRVINE, Calif., Oct. 29, 2025 /PRNew...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US4277461020
Heron Therapeutics Inc
HRTX
LISTED
NASDAQ
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
News Preview
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board of Directors. Mr. Cusack has extensive experience in matters related to corporate finance, investment management, and corporate go...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA)....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Deadline Alert: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR)....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Deadline Approaching: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Deadline Approaching: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”).
IF...
Themefolio
Profiler
Peergroup
© Newsfile
29.10.2025
ISIN: CA25380E1060
Digicann Ventures Inc.
DCNN
LISTED
CSE
Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc.
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Ltd. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that on October 22, 2025 it entered into a Termination, Settlement and Release Agreement (the "Settlement Agreement")...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Encompass Health reports results for third quarter 2025
News Preview
Increases full-year guidance
BIRMINGHAM, Ala., Oct. 29, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the thi...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9139031002
Universal Health Services Inc
UHS
LISTED
NYSE
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT THE 2025 WOLFE RESEARCH HEALTHCARE CONFERENCE
News Preview
KING OF PRUSSIA, Pa., Oct. 29, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the Wolfe Research Healthcare Conference 2025 in New York, New York on Wednesday, November 19, 2025, at 8:00 a.m. EST.
A live audio webcast of the presentation and a webcast r...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Announces Release of 2024 Sustainability Report
News Preview
BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2024 Sustainability Report, highlighting ongoing efforts to pursue progress with purpose as it integrates sustainable and responsible business practices to achieve its mission of partnering wit...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8688731004
Surmodics Inc
SRDX
LISTED
NASDAQ
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
News Preview
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic thrombotic limb ischemia patients from its PROWL registry study were presented by Dr. Peter Monteleone at the...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0905722072
Bio Rad Laboratories, Inc.
BIO
LISTED
NYSE
Bio-Rad Reports Third-Quarter 2025 Financial Results
News Preview
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2025.
“During the third quarter, we continued to navigate a dynamic global environment and evolving conditions across the markets for our life sc...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion to Participate in the Stifel 2025 Healthcare Conference
News Preview
ATLANTA, Oct. 29, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025, at the Lotte New York Palace Hotel. The Company'...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Proposed Public Offering
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. The proposed of...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23918K1088
DaVita Inc
DVA
LISTED
NYSE
DaVita Inc. 3rd Quarter 2025 Results
News Preview
DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025.
"Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance," said Javier Rodriguez, CEO of...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US89377M1099
Transmedics Group Inc
TMDX
LISTED
NASDAQ
TransMedics Reports Third Quarter 2025 Financial Results
News Preview
ANDOVER, Mass., Oct. 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Reports Third Quarter 2025 Results
News Preview
Q3 revenue growth of 12% year-over-year
Q3 net income of $30.6 million and non-GAAP net income of $67.8 million
Q3 net income margin of 11%; adjusted EBITDA margin of 42%...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
News Preview
Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic Status
Additional Poster Presentations Scheduled for American Heart Association Scientific S...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US2854091087
Electromed, Inc.
ELMD
LISTED
XASE
Electromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025
News Preview
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos Announces Third Quarter 2025 Financial Results
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the third quarter ended September 30, 2025. Key highlights include:
Record net sales of $133.5 million in Q3 2025 i...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:3...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
For the three-month period ended September 30, 2025, as compared to the same period of 2024:
Reported total revenue of $265.2 million, an increase of 39%...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces Third Quarter 2025 Financial Results
News Preview
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'25"). Q3'25 total reve...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
GRAIL to Announce Third Quarter 2025 Financial Results
News Preview
Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13th
MENLO PARK, Calif., Oct. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results
News Preview
Fanapt® Q3 2025 net product sales increased by 31% to $31.2 million compared to Q3 2024
BysantiTM (milsaperidone) NDA for bipolar I disorder and schizophrenia under review by the FDA; PDUFA target action date of February 21, 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
News Preview
THOUSAND OAKS, Calif., Oct. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agreement with funds managed by RTW Investments, LP (RTW), subject to FDA approval of MOLBREEVI.
“This non-dilutive strategic financing will support the U.S. launch of MOLBREEVI, assum...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase comm...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US04963C2098
AtriCure Inc
ATRC
LISTED
NASDAQ
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2025 financial results.
“Our third quarter results demonstrate strong execution and patient focus across the business. We...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
News Preview
Cytek has launched a two-part research support initiative to make cell analysis more accessible....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces ClinCheck® Live Plan That Automates Doctor-Ready Initial Invisalign® Treatment Plan in Minutes
News Preview
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced ClinCheck® Live Plan, a new feature in its Invisalign® digital treatment planning that automates the generation of in...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time.
Interested parties are invited to listen to the conference call and view...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Announces New Innovations for iTero™ Digital Solutions, a Comprehensive Ecosystem That Includes Intraoral Scanners and Integrated Software Tools That Enhance the Chairside Patient Experience
News Preview
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced a series of new product innovations for iTero™ Digital Solutions, a comprehensive ecosystem that includes intraoral s...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: IE00BFY8C754
STERIS plc
STE
LISTED
NYSE
STERIS Announces Dividend of $0.63 per share
News Preview
DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US75062E1064
Rafael Holdings Inc
RFL
LISTED
NYSE
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
News Preview
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee (DMC) following their review of prespecified safety and efficacy date at 48 weeks...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
News Preview
GAITHERSBURG, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Reports Third Quarter 2025 Results
News Preview
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025
News Preview
VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025
News Preview
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2025 financial results will be released before the market opens on November 5, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US68375N1037
OPKO Health Inc
OPK
LISTED
TLV
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
News Preview
Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
News Preview
Collaboration Highlights Minimally Invasive Neurovascular Stroke Treatment and Expands Public Awareness on Early Recognition and Access to Care
DANVILLE, Pa. and ALISO VIEJO, Calif., Oct. 29, 2025 /PRNewswire/ -- In honor...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc.
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectly that Levi & Korsinsky filed the case. This press release makes that...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US2528281080
Dianthus Therapeutics Inc
DNTH
LISTED
NASDAQ
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
News Preview
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced offering of 12,727,272 shares of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will present at the Spartan Capital Securities Inv...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
News Preview
ATLANTA, Oct. 29, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the opening of applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis (MG) including patients, caregivers, and family members who are pursuing f...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
